Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) EBT Margin (2016 - 2026)

Iradimed has reported EBT Margin over the past 14 years, most recently at 35.35% for Q1 2026.

  • Quarterly EBT Margin rose 488.0% to 35.35% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 34.98% through Mar 2026, up 175.0% year-over-year, with the annual reading at 33.84% for FY2025, 69.0% up from the prior year.
  • EBT Margin was 35.35% for Q1 2026 at Iradimed, up from 34.33% in the prior quarter.
  • Over five years, EBT Margin peaked at 38.83% in Q3 2023 and troughed at 24.86% in Q1 2022.
  • The 5-year median for EBT Margin is 32.85% (2023), against an average of 32.72%.
  • Year-over-year, EBT Margin soared 1392bps in 2022 and then tumbled -381bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 31.64% in 2022, then rose by 3bps to 32.56% in 2023, then grew by 1bps to 32.72% in 2024, then increased by 5bps to 34.33% in 2025, then increased by 3bps to 35.35% in 2026.
  • Per Business Quant, the three most recent readings for IRMD's EBT Margin are 35.35% (Q1 2026), 34.33% (Q4 2025), and 34.42% (Q3 2025).